@prefix : <http://www.s-cubed.dk/ZDUMMYMED/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZDUMMYMED/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#0ee365e5-36aa-4bbd-b247-972f931b1e0c>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#201434a1-f50d-4e21-8cb7-53acef725942>
	rdf:type pr:Epoch ;
	isoC:label "Double Blind Treatment"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#3cf4d9f6-2356-4a3a-90aa-0cdc5f625f40>
	rdf:type pr:Epoch ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#7de7ad4d-7016-4eb2-abd2-5bac415542cd>
	rdf:type pr:Arm ;
	isoC:label "ZD CP"^^xsd:string ;
	pr:description "Regimen ZD, CP"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#e124e8e7-92ac-4b74-885d-650666e75498>
	rdf:type pr:Arm ;
	isoC:label "CP ZD"^^xsd:string ;
	pr:description "Regimen CP, ZD"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#1ad39a0d-2c9a-47a5-842b-516414c20c02>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#7de7ad4d-7016-4eb2-abd2-5bac415542cd> ;
	pr:inEpoch <http://www.assero.co.uk/EP#0ee365e5-36aa-4bbd-b247-972f931b1e0c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
.
<http://www.assero.co.uk/ELE#3ad711e2-feb1-469c-947f-b0cdcb9e3325>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#e124e8e7-92ac-4b74-885d-650666e75498> ;
	pr:inEpoch <http://www.assero.co.uk/EP#0ee365e5-36aa-4bbd-b247-972f931b1e0c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
.
<http://www.assero.co.uk/ELE#d1d4e488-2352-4601-9445-fc3ab02f51bb>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#7de7ad4d-7016-4eb2-abd2-5bac415542cd> ;
	pr:inEpoch <http://www.assero.co.uk/EP#201434a1-f50d-4e21-8cb7-53acef725942> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#3fa474c0-df5a-4f5c-b967-89748e1c981c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#770bbfc4-5d26-44fc-9e36-8752c1a90641> ;
.
<http://www.assero.co.uk/ELE#863e5d5a-9197-4e21-a3f8-c6693ce32070>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#e124e8e7-92ac-4b74-885d-650666e75498> ;
	pr:inEpoch <http://www.assero.co.uk/EP#201434a1-f50d-4e21-8cb7-53acef725942> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#3fa474c0-df5a-4f5c-b967-89748e1c981c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#770bbfc4-5d26-44fc-9e36-8752c1a90641> ;
.
<http://www.assero.co.uk/ELE#cc1378c5-9b20-405a-9536-d2b1880d566a>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#7de7ad4d-7016-4eb2-abd2-5bac415542cd> ;
	pr:inEpoch <http://www.assero.co.uk/EP#3cf4d9f6-2356-4a3a-90aa-0cdc5f625f40> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#9c852c20-4a54-42dd-b68f-6c58b477e5b0> ;
.
<http://www.assero.co.uk/ELE#4e4b2641-36c9-42fd-a71b-bba9edf9453a>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#e124e8e7-92ac-4b74-885d-650666e75498> ;
	pr:inEpoch <http://www.assero.co.uk/EP#3cf4d9f6-2356-4a3a-90aa-0cdc5f625f40> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#9c852c20-4a54-42dd-b68f-6c58b477e5b0> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZDUMMYMED"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-12T17:09:16+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZDUMMYMED"^^xsd:string ;
	pr:title "A 26 weeks, randomized, double-blind, comparator-controlled, cross-over group, Efficacy and Safety trial of once daily ZD 5mg oral, as add-on to Basal Insulin in Elderly (>60 years old) Type 2 Diabetes Mellitus patients with insufficient glycemic control."^^xsd:string ;
	pr:shortTitle "ZDUMMYMED"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#7de7ad4d-7016-4eb2-abd2-5bac415542cd> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#e124e8e7-92ac-4b74-885d-650666e75498> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#0ee365e5-36aa-4bbd-b247-972f931b1e0c> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#201434a1-f50d-4e21-8cb7-53acef725942> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#3cf4d9f6-2356-4a3a-90aa-0cdc5f625f40> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#d386658f-4f72-4aeb-be2f-2d5e35be6269> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#3685a618-8d0d-411c-b788-f6be7cb1b223> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#11de281d-12e7-4716-aa00-07a675efa245> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#600e1889-a970-4ca0-a5de-c4597205e776> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZDUMMYMED"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V42#C66737_C15602> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V28#C99076_C82637> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66735/V4#C66735_C15228> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 12"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 18"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/VI#50347305a9cc2e647f8a8e7487c9a46cefa1e690>
	rdf:type pr:Visit ;
	isoC:label "Week 24"^^xsd:string ;
	pr:shortName "Vis#06"^^xsd:string ;
.
<http://www.assero.co.uk/VI#897ded48a15c04d82654d57ae11bac9e9445f877>
	rdf:type pr:Visit ;
	isoC:label "End of Study"^^xsd:string ;
	pr:shortName "Vis#07"^^xsd:string ;
.
<http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_459de868-d521-45d9-a086-bc1afb771415> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
.
<http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_35ec3ae2-4834-4df4-bd61-1cd948d70ff4> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
.
<http://www.assero.co.uk/TP#3fa474c0-df5a-4f5c-b967-89748e1c981c>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_79bf5526-a5d7-41ab-ae3e-381bc269179a> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
.
<http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_9499c8e6-9aa7-422c-bdad-fa67a382a2bb> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
.
<http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_b4afad2e-2e44-425f-a717-b84a6c77bc8b> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/TP#770bbfc4-5d26-44fc-9e36-8752c1a90641>
	rdf:type pr:Timepoint ;
	isoC:label "TP6"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_b4afad2e-2e44-425f-a717-b84a6c77bc8b> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/TP#9c852c20-4a54-42dd-b68f-6c58b477e5b0>
	rdf:type pr:Timepoint ;
	isoC:label "TP7"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_b4afad2e-2e44-425f-a717-b84a6c77bc8b> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
.
<http://www.assero.co.uk/IC#TPO_459de868-d521-45d9-a086-bc1afb771415>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "0"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_35ec3ae2-4834-4df4-bd61-1cd948d70ff4>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_79bf5526-a5d7-41ab-ae3e-381bc269179a>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "3628800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_9499c8e6-9aa7-422c-bdad-fa67a382a2bb>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "7257600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_b4afad2e-2e44-425f-a717-b84a6c77bc8b>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "10886400"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_9945fd18-c942-4a2a-9528-8c1dbd99f47c>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "14515200"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_8106ef74-33c7-4810-938a-34ca913c9ad3>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "15120000"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#d386658f-4f72-4aeb-be2f-2d5e35be6269>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#fccffc31-6455-4b1a-b02c-57ef8d9d2140> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#1fe13dba-4eb7-4643-8a27-a51ae70fcc84> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#3685a618-8d0d-411c-b788-f6be7cb1b223>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#c922bc41-6ffa-453e-8eb3-aa5726d4b4fc> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#11de281d-12e7-4716-aa00-07a675efa245>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#c465bf2d-4eed-48e5-a09c-f1567606edf9> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#0cfac7ae-6e4a-40eb-84f3-1af2831d7437> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#77fd6875-9fe4-4246-befc-2cf974eb9435> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#883ab85f-e365-4df6-bda2-970a8591e37b> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#600e1889-a970-4ca0-a5de-c4597205e776>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#5502778d-88a5-4387-92a9-5392f2832a35> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#e6d8bde2-110c-47ab-83c1-05ad0b5a29ae>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#0fd9abfb-6158-4061-a871-481afe146055> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#fccffc31-6455-4b1a-b02c-57ef8d9d2140>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
.
<http://www.assero.co.uk/PREND#1fe13dba-4eb7-4643-8a27-a51ae70fcc84>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
.
<http://www.assero.co.uk/PREND#c922bc41-6ffa-453e-8eb3-aa5726d4b4fc>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
.
<http://www.assero.co.uk/PREND#c465bf2d-4eed-48e5-a09c-f1567606edf9>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
.
<http://www.assero.co.uk/PREND#0cfac7ae-6e4a-40eb-84f3-1af2831d7437>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#3fa474c0-df5a-4f5c-b967-89748e1c981c> ;
.
<http://www.assero.co.uk/PREND#77fd6875-9fe4-4246-befc-2cf974eb9435>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#3fa474c0-df5a-4f5c-b967-89748e1c981c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#527e2d6c-a732-4bc4-a945-2ca0ed870873> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d6d498d8-8f27-45a1-a673-103508e6aa5d> ;
.
<http://www.assero.co.uk/PREND#883ab85f-e365-4df6-bda2-970a8591e37b>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
.
<http://www.assero.co.uk/PREND#5502778d-88a5-4387-92a9-5392f2832a35>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
.
<http://www.assero.co.uk/PREND#0fd9abfb-6158-4061-a871-481afe146055>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#0187843d-3583-4880-98ce-2ed8629d319c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#edd87367-0f44-45c7-a94a-9a43a8aac27a> ;
.